Translational control of inducible nitric oxide synthase by p38 MAPK in islet β-cells

Molecular Endocrinology

Volumn 27, Issue 2, 2013, Pages 336-349

  Nishiki, Yurika ^a   Adewola, Adeola ^a   Hatanaka, Masayuki ^a   Templin, Andrew T ^a   Maier, Bernhard ^a   Mirmira, Raghavendra G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACONITATE HYDRATASE; CYCLOHEXIMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; INITIATION FACTOR 5A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) METHYLARGININE; N1 GUANYL 1,7 DIAMINOHEPTANE; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; OXYGEN CONSUMPTION; PANCREAS ISLET BETA CELL; POLYSOME; PRIORITY JOURNAL; RAT; RNA TRANSLATION; TRANSCRIPTION ELONGATION;

ACONITATE HYDRATASE; ANIMALS; CELL LINE; CYCLOHEXIMIDE; CYTOKINES; ENZYME INHIBITORS; GUANINE; HUMANS; IMIDAZOLES; INSULIN; INSULIN-SECRETING CELLS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 14; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; PEPTIDE INITIATION FACTORS; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS;

EID: 84873020959     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1230     Document Type: Article

References (49)

1. Tersey SA, Nishiki Y, Templin AT, Cabrera SM, Stull ND, Colvin SC, Evans-Molina C, Rickus JL, Maier B, Mirmira RG 2012 Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 61:818-827
2. Robbins RD, Tersey SA, Ogihara T, Gupta D, Farb TB, Ficorilli J, Bokvist K, Maier B, Mirmira RG 2010 Inhibition of deoxyhypusine synthase enhances islet β cell function and survival in the setting of endoplasmic reticulum stress and type 2 diabetes. J Biol Chem 285:39943-39952
3. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY 2007 Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517-1526
4. Eguchi K, Manabe I, Oishi-Tanaka Y, Ohsugi M, Kono N, Ogata F, Yagi N, Ohto U, Kimoto M, Miyake K, Tobe K, Arai H, Kadowaki T, Nagai R 2012 Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. Cell Metab 15:518-533
5. Fontés G, Zarrouki B, Hagman DK, Latour MG, Semache M, Roskens V, Moore PC, Prentki M, Rhodes CJ, Jetton TL, Poitout V 2010 Glucolipotoxicity age-dependently impairs β cell function in rats despite a marked increase in β cell mass. Diabetologia 53:2369-2379
6. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC 2003 β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
7. Ogihara T, Mirmira RG 2010 An islet in distress: β cell failure in type 2 diabetes. J Diab Invest 1:123-133
8. Lowenstein CJ, Padalko E 2004 iNOS (NOS2) at a glance. J Cell Sci 117:2865-2867
9. Corbett JA, McDaniel ML 1994 Reversibility of interleukin-1 β-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem J 299:719-724
10. Hughes KJ, Chambers KT, Meares GP, Corbett JA 2009 Nitric oxides mediates a shift from early necrosis to late apoptosis in cytokine-treated β-cells that is associated with irreversible DNA damage. Am J Physiol Endocrinol Metab 297:E1187-E1196
11. Oyadomari S, Takeda K, Takiguchi M, Gotoh T, Matsumoto M, Wada I, Akira S, Araki E, Mori M 2001 Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci USA 98:10845-10850
12. Cardozo AK, Ortis F, Storling J, Feng YM, Rasschaert J, Tonnesen M, Van Eylen F, Mandrup-Poulsen T, Herchuelz A, Eizirik DL 2005 Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic β-cells. Diabetes 54:452-461
13. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ 1994 Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612-1615
14. Xie QW, Kashiwabara Y, Nathan C 1994 Role of transcription factor NF-κ B/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705-4708
15. Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, Chakrabarti SK, Nunemaker CS, Stull ND, Taylor CA, Thompson JE, Dondero RS, Lewis EC, Dinarello CA, Nadler JL, Mirmira RG 2010 The unique hypusine modification of eIF5A promotes islet β cell inflammation and dysfunction in mice. J Clin Invest 120:2156-2170
16. Jang BC, Sung SH, Park JG, Park JW, Suh MH, Choi IH, Yoshida M, Yoo SK, Suh SI 2006 Leptomycin B, a metabolite of Streptomyces, inhibits the expression of inducible nitric oxide synthase in BV2 microglial cells. Int J Oncol 29:1509-1515
17. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C 1993 Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J Exp Med 178:605-613
18. Park MH, Nishimura K, Zanelli CF, Valentini SR 2010 Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids 38:491-500
19. Maier B, Tersey SA, Mirmira RG 2010 Hypusine: a new target for therapeutic intervention in diabetic inflammation. Discov Med 10:18-23
20. Raman M, Chen W, Cobb MH 2007 Differential regulation and properties of MAPKs. Oncogene 26:3100-3112
21. Gehart H, Kumpf S, Ittner A, Ricci R 2010 MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep 11:834-840
22. Lui P, Zeng C, Acton S, Cok S, Sexton A, Morrison AR 2004 Effects of p38MAPK isoforms on renal mesangial cell inducible nitric oxide synthase expression. Am J Physiol Cell Physiol 286:C145-C152
23. Bhat NR, Zhang P, Lee JC, Hogan EL 1998 Extracellular signalregulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-β gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18:1633-1641
24. Chen C, Chen YH, Lin WW 1999 Involvement of p38 mitogenactivated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 97:124-129
25. Larsen CM, Wadt KA, Juhl LF, Andersen HU, Karlsen AE, Su MS, Seedorf K, Shapiro L, Dinarello CA, Mandrup-Poulsen T 1998 Interleukin-1β-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem 273:15294-15300
26. Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB 2000 Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and-independent glucosestimulated insulin secretion. Diabetes 49:424-430
27. Stull ND, Breite A, McCarthy RC, Tersey SA, Mirmira RG 2012 Mouse islet of Langerhans isolation using a combination of purified collagenase and neutral protease. J Vis Exp 67:4137
28. Porras A, Zuluaga S, Black E, Valladares A, Alvarez AM, Ambrosino C, Benito M, Nebreda AR 2004 P38 α mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 15:922-933
29. Sadowski HB, Gilman MZ 1993 Cell-free activation of a DNAbinding protein by epidermal growth factor. Nature 362:79-83
30. Iype T, Francis J, Garmey JC, Schisler JC, Nesher R, Weir GC, Becker TC, Newgard CB, Griffen SC, Mirmira RG 2005 Mechanism of insulin gene regulation by the pancreatic transcription factor Pdx-1: application of pre-mRNA analysis and chromatin immunoprecipitation to assess formation of functional transcriptional complexes. J Biol Chem 280:16798-16807
31. Evans-Molina C, Garmey JC, Ketchum R, Brayman KL, Deng S, Mirmira RG 2007 Glucose regulation of insulin gene transcription and pre-mRNA processing in human islets. Diabetes 56:827-835
32. Corbett JA, Wang JL, Sweetland MA, Lancaster Jr JR, McDaniel ML 1992 Interleukin 1 β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. Evidence for the β-cell as a source and site of action of nitric oxide. J Clin Invest 90:2384-2391
33. Guan Z, Buckman SY, Springer LD, Morrison AR 1999 Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1β in rat glomerular mesangial cells. J Biol Chem 274:36200-36206
34. Teske BF, Baird TD, Wek RC 2011 Methods for analyzing eIF2 kinases and translational control in the unfolded protein response. Methods Enzymol 490:333-356
35. Park MH, Wolff EC, Lee YB, Folk JE 1994 Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines. J Biol Chem 269:27827-27832
36. Umland TC, Wolff EC, Park MH, Davies DR 2004 A new crystal structure of deoxyhypusine synthase reveals the configuration of the active enzyme and of an enzyme. NAD. inhibitor ternary complex. J Biol Chem 279:28697-28705
37. Keskinen P, Korhonen S, Kupila A, Veijola R, Erkkilä S, Savolainen H, Arvilommi P, Simell T, Ilonen J, Knip M, Simell O 2002 Firstphase insulin response in young healthy children at genetic and immunological risk for Type I diabetes. Diabetologia 45:1639-1648
38. Ferrannini E, Mari A, Nofrate V, Sosenko JM, Skyler JS, DPT-1 Study Group 2010 Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. Diabetes 59:679-685.
39. Fukunaga R, Hunter T 1997 MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 16:1921-1933
40. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA 1997 Mitogenactivated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 16:1909-1920
41. Wang X, Flynn A, Waskiewicz AJ, Webb BL, Vries RG, Baines IA, Cooper JA, Proud CG 1998 The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J Biol Chem 273:9373-9377
42. Knebel A, Morrice N, Cohen P 2001 A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38δ. EMBO J 20:4360-4369
43. Sonenberg N, Hinnebusch AG 2009 Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136:731-745
44. Dever TE, Green R 2012 The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb Perspect Biol 4:a013706-a013706
45. Kemper WM, Berry KW, Merrick WC 1976 Purification and properties of rabbit reticulocyte protein synthesis initiation factors M2Bα and M2Bβ. J Biol Chem 251:5551-5557
46. Saini P, Eyler DE, Green R, Dever TE 2009 Hypusine-containing protein eIF5A promotes translation elongation. Nature 459:118-121
47. Li CH, Ohn T, Ivanov P, Tisdale S, Anderson P 2010 eIF5A promotes translation elongation, polysome disassembly and stress granule assembly. PLoS ONE 5:e9942
48. Henderson A, Hershey JW 2011 Eukaryotic translation initiation factor (eIF) 5A stimulates protein synthesis in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 108:6415-6419
49. Kruse M, Rosorius O, Kratzer F, Bevec D, Kuhnt C, Steinkasserer A, Schuler G, Hauber J 2000 Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J Exp Med 191:1581-1590